Our study sought to identify sociodemographic, clinical, life perception, and service use characteristics that distinguish new cases of people dependent on substances from the general population; and to determine predictors of substance dependence over a 2-year period. Variables that differentiate people dependent on substances according to sex and age were also assessed.
Methods:
Among 2434 people who took part in an epidemiologic catchment area health survey at baseline, 2.2% were identified with substance dependence at the second measurement time only. Using a comprehensive framework, various aspects were considered as predictors for multivariate statistics.
Results:
Participants with substance dependence at time 2 only showed worse clinical conditions, life events, life and health perception, and neighbourhood characteristics than other participants, but only 2.5% used health care services. Male sex, younger age, stigmatization, and impulsiveness were predictors of substance dependence. Regarding sex, females with dependence were only more likely to suffer from social phobia than males. In terms of age categories, participants over 50 with substance dependence were more likely to have a lower household income and less social support than younger people.
Conclusion:
Stigmatization was the strongest predictor of substance dependence. Our study also confirmed that males and younger people were more likely to have substance dependence. Anti-stigmatization, prevention, and outreach programs are needed to overcome the reluctance of this clientele to use health care services. Health professionals should also pay more attention to life and health perception and neighbourhood characteristics of newly identified drug users.
EnochMA. The role of early life stress as a predictor for alcohol and drug dependence. Psychopharmocology. 2011;214(1):17–31.
2.
HasinDSStinsonFSOgburnE, Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2007;64(7):830–842.
3.
ComptonWMThomasYFStinsonFS, Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: Results form the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2007;64(5):566–576.
4.
RushBRUrbanoskiKABassaniDG, The epidemiology of co-occurring substance use and other mental disorders in Canada: Prevalence, service use, and unmet needs. In: CairneyJStreinerDL, editors. Mental disorder in Canada. An epidemiological perspective. Toronto (ON): University of Toronto Press; 2010. p 170–204.
5.
CastelSRushBRUrbanoskiK, Overlap of clusters of psychiatric symptoms among clients of a comprehensive addiction treatment service. Psychol Addict Behav. 2006;20(1):28–35.
6.
KesslerRC. The epidemiology of dual diagnosis. Biol Psychiatry. 2004;56(10):730–737.
7.
KesslerRCNelsonCBMcGonagleKA, The epidemiology of co-occurring addictive and mental disorders: Implications for prevention and service utilization. Am J Orthopsychiatry. 1996;66(1):17–31.
8.
GrantBFHasinDSStinsonFS, The epidemiology of DSM-IV panic disorder and agoraphobia in the United States; results form the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2006;67(3):363–374.
9.
KandelDBHuangFYDaviesM.Comorbidity between patterns of substance use dependence and psychiatric syndromes. Drug Alcohol Depend. 2001;64(2):233–241.
10.
CassidyFAhearnEPCarrollBJ. Substance abuse in bipolar disorder. Bipolar Disord. 2001;3(4):181–188.
11.
GrellaCE. Effects of gender and diagnosis on addiction history, treatment utilization, and psychosocial functioning among a dually-diagnosed sample in drug treatment. J Psychoactive Drugs. 2003;35(Suppl 1):169–179.
12.
FordJDGelernterJDeVoeJS, Association of psychiatric and substance use disorder comorbidity with cocaine dependence severity and treatment utilization in cocaine-dependent individuals. Drug Alcohol Depend. 2009;99(1–3):193–203.
13.
McGovernMPClarkRESamnalievM.Co-occurring psychiatric and substance use disorders: A multistate feasibility study of the quadrant model. Psychiatr Serv. 2007;58(7):949–954.
14.
UrbanoskiKARushBRWildTC, Use of mental health care services by Canadians with co-occurring substance dependence and mental disorders. Psychiatr Serv. 2007;58(7):962–969.
15.
EdlundMJHarrisKM. Perceived effectiveness of medications among mental health service users with and without alcohol dependence. Psychatr Serv. 2006;57(5):692–699.
16.
UrbanoskiKCairneyJBassaniDG, Perceived unmet need for mental health care for Canadians with co-occurring mental and substance use disorders. Psychiatr Serv. 2008;59(3):283–289.
17.
KesslerRCMcGonagleKAZhaoS, Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results form the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51(1):8–19.
18.
GrellaCESteinJA. Impact of program services on treatment outcomes of patients with comorbid mental and substance use disorders. Psychiatr Serv. 2006;57(7):1007–1015.
19.
WatkinsKEBurnamAKungF Y, A national survey of care for persons with-co-occuring mental and substance use disorders. Psychiatr Serv. 2001;52(8):1062–1068.
20.
KesslerRCZhaoSKatzSJ, Past-year use of outpatient services for psychiatric problems in the National Comorbidity Survey. Am J Psychiatry. 1999;156(1):115–123.
21.
ComptonWMCottlerLBBen AbdallahA, Substance dependence and other psychiatric disorders among drug dependent subjects: Race and gender correlates. Am J Addict. 2000;9(2):113–125.
22.
CaronJFleuryMJPerreaultM, Prevalence of psychological distress and mental disorders, and use of mental health services in the epidemiological catchement area of Montreal South-West. BMC Psychiatry. 2012;12:183.
23.
FleuryMJGrenierGBamvitaComprehensive determinants of health service utilisation for mental health reasons in a Canadian catchment area. Int J Equity Health. 2012;11:20.
24.
TorreyWCDrakeRECohenM, The challenge of implementing and sustaining integrated dual disorder treatment programs. Community Ment Health J. 2002;38(6):507–521.
25.
EatonWWAnthonyJCTepperS, Psychopathology and attrition in the epidemiologic catchment area surveys. Am J Epidemiol. 1992;135(9):1051–1059.
26.
de GraafRBijlRVSmitF, Psychiatric and sociodemographic predictors of attrition in a longitudinal study: The Netherlands Mental Health Survey and Incidence Study (NEMESIS). Am J Epidemiol. 2000;152(11):1039–1047.
27.
BucholzKKShaykaJJMarionSL, Is a history of alcohol problems or of psychiatric disorder associated with attrition at 11-year follow-up?Ann Epidemiol. 1996;6(3):228–234.
28.
Statistics Canada. Canadian Community Health Survey (CCHS)—mental health and well-being (cycle 1.2).Ottawa (ON): Statistics Canada; 2002.
29.
VegaWAKolodyBAguilar-GaziolaS, Lifetime prevalence of DSM-III-R psychiatric disorders among urban and rural Mexican Americans in California. Arch Gen Psychiatry. 1998;55(9):771–778.
30.
BijlRVRavelliAvan ZesseenG.Prevalence of psychiatric disorder in the general population: Results of the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Soc Psychiatry Psychiatr Epidemiol. 1998;33(12):587–595.
31.
KesslerRCBarkerPRColpeLJ, Screening for serious mental illness in the general population. Arch Gen Psychiatry. 2003;60(2):184–189.
32.
BarrattES. Impulsiveness subtraits: Arousal and information processing. In: SpenceJTIzardsCE, editors. Motivation, emotion and personality. Philadelphia (PA): Elsevier Science Publishers; 1985. p 137–146.
33.
CutronaCE. Behavioral manifestation of social support: A micro-analytic study. J Pers Soc Psychol. 1989;51(1):201–208.
34.
BakerFIntagliataJ.Quality of life in the evaluation of community support systems. Eval Prorgram Plann. 1982;5(1):69–79.
35.
LinkB.Understanding labelling effects in the area of mental disorders: An assessment of the effects of expectations of rejection. Am Sociol Rev. 1987;52(1):96–112.
36.
KaySRWolkenfiedFMurrillLM. Profiles of aggression among psychiatrist patients. I. Nature and prevalence. J Nerv Ment Dis. 1988;176(9):539–546.
37.
Nario-RedmondMCoultonCMulliganSE. Measuring resident perceptions of neighborhood conditions: Survey methodology. Cleveland (OH): Case Western Reserve University, Mandel School of Applied Social Sciences, Center on Urban Poverty and Social Change; 2000.
38.
CoultonCJKorbinJESuM.Measuring neighborhood context for young children in an urban area. Am J Community Psychol. 1996;24(1):5–32.
39.
DennisMLScottCKFunkR, The duration and correlates of addiction and treatment careers. J Subst Abuse Treat. 2005;28(Suppl 1):S51–S62.
40.
GrellaCEHserYIHsiehSC. Predictors of drug treatment re-entry following relapse to cocaine use in DATOS. J Subst Abuse Treat. 2003;28(Suppl 1):S51–S62.
41.
RitsherJBMcKellarJDFinneyJW, Psychiatric comorbidity, continuing care and mutual help as predictors of five-year remission for substance use disorders. J Stud Alcohol. 2002;63(6):709–715.
42.
LaudetABMaguraSVogelHS, Support, mutual aid and recovery from dual diagnosis. Community Ment Health J. 2000;36(5):321–329.
43.
TuchmanE.Woman and addiction: The importance of gender issues in substance abuse research. J Addict Dis. 2010;29(2):127–138.
44.
KeyesKMHatzenbuehlerMLMcLaughlinKA, Stigma and treatment for alcohol disorders in the United States. Am J Epidemiol. 2010;172(12):1364–1372.
45.
SchulzeBAngermeyerMC. Subjective experiences fo stigma. A focus group study of schizophrenic patients, their relatives and mental health professionals. Soc Sci Med. 2003;56(2):299–312.
46.
StuartH.Stigmatisation. Leçons tirées des programmes visant sa diminution. Sante Ment Que. 2003;28(1):54–72.
47.
PrincePNPrinceCR. Perceived stigma and community integration among clients of assertive community treatment. Psychiatr Rehabil J. 2002;25(4):323–331.
48.
RushBRUrbanoskiKBassaniDG, Prevalence of co-occurring substance use and other mental disorders in the Canadian population. Can J Psychiatry. 2008;53(12):800–809.
49.
de GraafRBijlRVRavelliA, Predictors of first incidence of DSM-III-R psychiatric disorders in the general population: Findings from the Netherlands Mental Health Survey and Incidence Study. Acta Psychiatr Scand. 2002;106(4):303–313.
50.
EncrenazGMessiahA.Lifetime psychiatric comorbidity with substance use disorders: Does healthcare use modify the strength of associations?Soc Psychiatry Psychiatr Epidemiol. 2006;41(5):378–385.
51.
BlanchardJJBrownSAHoranWP, Substance use disorders in schizophrenia: Review, integration, and a proposed model. Clin Psychol Rev. 2000;20(2):207–234.
52.
JacobiFWittchenHUHoltingC, Prevalence, co-morbidity and correlates of mental disorders in the general population: Results from the German Health Interview and Examination Survey (GHS). Psychol Med. 2004;34(4):597–611.
53.
WilsonNJCadetJL. Comorbid mood, psychosis, and marijuana abuse disorders: A theoretical review. J Addict Dis. 2009;28(4):309–319.
54.
FentonMCKeyesKGreierT, Psychiatric comorbidity and the persistence of drug use disorders in the United States. Addiction. 2012;107(3):599–609.
55.
MoellerFGDoughertyDMBarratES, The impact of impulsivity on cocaine use and retention in treatment. J Subst Abuse Treat. 2001;21(4):193–198.
56.
MarinoENRosenKDGutierrezA, Impulsivity but not sensation seeking is associated with opioid analgesic misuse risk in patients with chornic pain. Addict Behav. 2013;36(5):2154–2157.
57.
JakubczykAWrzosekMLukaszkiewiczJ, The CC genotype in HTR2A T102C polymorphism is associated with behavioral impulsivity in alcohol-dependent patients. J Psychiatric Res. 2012;46(1):44–49.
58.
Karray-KhemiriADerivoisD.L'addiction à l'adolescence: Entre affect et cognition. Symbolisation, inhibition cognitive et alexithymie. Drogues Santé Société. 2011;10(2):15–50.
59.
BoardmanJDFinchBKEllisonCG, Neighborhood disadvantage, stress and drug use among adults. J Health Soc Behav. 2001;42(2):151–165.
60.
KesslerRCAiguilar-GaxiolaSBerglundPA, Patterns and predictors of treatment seeking after onset of a substance use disorder. Arch Gen Psychiatry. 2001;58:1065–1071.
61.
WuLTPilowskyDJSchlengerWE, Alcohol use disorders and the use for treatment services among college-age young adults. Psychiatr Serv. 2007;58(2):192–200.
62.
SpandorferJMIsraelYTurnerBJ. Primary care physicians' views on screening and management of alcohol abuse: Inconsistencies with national guidelines. J Fam Pract. 1999;48:899–902.
63.
VerduinMLCarterREBradyKT, Health service use among persons with comorbid bipolar and substance use disorders. Psychiatr Serv. 2005;56(4):475–480.
64.
MorrisonAElliotLGruerL.Injected-related harm and treatment-seeking behaviour among injecting drug users. Addiction. 1997;92:1349–1352.
65.
Statistique Canada. Enquête sur la santé dans les collectivités canadiennes: Santé mentale et bien-être. Le Quotidien. 3 sept. 2003.
66.
BradizzaCMStasiewiczPR, Paas ND. Relapse to alcohol and drug use among individuals diagnosed with co-occurring mental health and substance use disorders: A review. Clin Psychol Rev. 2006;26(2):162–178.
67.
HättenschwillerJRüeschPModestinJ.Comparison of four groups of substance-abusing in-patients with different psychiatric comorbidity. Acta Psychiatr Scand. 2001;104(1):59–65.
68.
MueserKTYarnoldPRBellackAS. Diagnostic and demographic correlates of substance abuse in schizophrenia and major affective disorder. Acta Psychiatr Scand. 1992;85(1):48–55.
69.
MorgensternJLangenbucherJLabouvieE, The comorbidity of alcoholism and personality disorders in a clinical population: Prevalence rates and relation to alcohol typology variables. J Abnorm Psychol. 1997;106(1):74–84.
70.
MarmorsteinNR. Anxiety disorders and substance use disorders: Different associations by anxiety disorder. J Anxiety Disord. 2012;26(1):88–94.
71.
GreenfiedTKRoomR.Situational norms for drinking and drunkness: Trends in the US adult population, 1979–1990. Addiction. 1997;92(1):33–47.
72.
WangPSLaneMOlfsonM, Twelve-month use of mental health services in the United States. Arch Gen Psychiatry. 2005;62(6):629–640.
73.
WarrenJISteinJAGrellaCE. Role of social support and self-efficacy in treatment outcomes among clients with co-occurring disorders. Drug Alcohol Depend. 2007;89(2–3):267–274.
74.
KellyTMDaleyDCDouaihyAB. Treatment of substance abusing patients with comorbid psychiatric disorders. Addict Behav. 2012;37(1):11–24.
75.
MulderRTFramptonCMPekaH, Predictors of 3-month retention in a drug treatment therapeutic community. Drug Alcohol Rev. 2009;28(4):366–371.
76.
MoosRHMoosBSAndrassyJM. Outcomes of four treatment approaches in community residential programs for patients with substance use disorders. Psychiatr Serv. 1999;50(12):1577–1583.
77.
McHugoGJKammererNJacksonEW, Women, Co-occurring Disorders, and Violence Study: Evaluation design and study population. J Subst Abuse Treat. 2005;28(2):91–107.
